Noroviruses, a major aetiological agent of gastroenteritis in humans (Atmar & Estes, 2006) , are classified into five genogroups (GI-GV), which are in turn divided into a number of genotypes (Zheng et al., 2006) . Surveillance since the 1990s has confirmed that genotype 4 of the GII genogroup (denoted GII.4) dominates most worldwide outbreaks of norovirus-related gastroenteritis (Jin et al., 2008; Kroneman et al., 2008; Nayak et al., 2009; Park et al., 2010; Siebenga et al., 2009) .
Over the past 20 years GII.4 norovirus has evolved a series of genetic variants, some of which persisted and replaced the previously circulating variants (Reuter et al., 2008; Siebenga et al., 2010) . The continuous evolution of the viral capsid VP1 protein has been proposed as a key mechanism by which new antigenic variants are generated. This is supported by observations of temporal changes in histoblood group antigen-binding characteristics, antigenic relatedness and genome composition among GII.4 norovirus variants (Lindesmith et al., 2008) . (Chan-It et al., 2011; Chung et al., 2010; Eden et al., 2010; Jin et al., 2008; Kittigul et al., 2010) . However, the '2008 variant' has been reported increasingly frequently since its first isolation in 2008 (Belliot et al., 2010; Motomura et al., 2010) and, at the time of writing, has been identified in 12 countries on four continents (Belliot et al., 2010; Eden et al., 2010; Han et al., 2011; Mans et al., 2010; Motomura et al., 2010; Pang et al., 2010; Schenk et al., 2010) . Previous phylogenetic analysis showed that the 2008 variant emerged from the Hunter-2006a ancestral lineage, with which it shares 88 % nucleotide similarity (Eden et al., 2010) . However, the phylogenetic position of the 2008 variant differed according to the genome region investigated (Belliot et al., 2010; Eden et al., 2010; Mans et al., 2010; Motomura et al., 2010) , with a recombination breakpoint identified at the ORF1-ORF2 junction of the Japanese 2008 variants (Motomura et al., 2010) .
To better understand the role of recombination in the evolutionary origin of the 2008 variant, partial and complete genome sequences of GII.4 noroviruses from GenBank were examined. After alignment using MUSCLE v3.8 (Edgar, 2004) , a maximum-likelihood (ML) phylogeny of GII.4 ORF2 sequences (1620 nt; n5600) was estimated using PhyML v3.0 (Guindon & Gascuel, 2003) . Topological robustness was assessed by performing ML bootstrap analysis (1000 pseudoreplicates; using PhyML) and Bayesian phylogeny sampling (5000 samplings, each at every 2000 states; using MrBayes 3.1.2; Ronquist & Huelsenbeck, 2003) . This revealed a distinct monophyletic lineage of variant strains (n535; Fig. 1 ) that was previously (Belliot et al., 2010; Mans et al., 2010) , and was also known as '2008a variant' according to Motomura et al. (2010) . Other known GII.4 variants are also identified in Fig. 1 
(colour bars).
Systematic screening for recombination was undertaken using the suite of statistical tests implemented in RDP v3.41 (Martin & Rybicki, 2000) . Sequences of 2008 variant viruses (1620 nt; n535; Supplementary Table S1, available in JGV Online) consistently exhibited a mosaic fragment about 300-500 nt long in the ORF2 P2 domain (statistically significant in .2 RDP tests, after Bonferroni correction). Results suggest that the 2006b and 2006a variants were the ancestors of the small and large ORF2 fragments, respectively. Next, we studied the complete genomes of 2008 variants (7509 bp; n511; Supplementary Table S1 ) that revealed similar breakpoints in the P2 region. However, all 2008 variants (except Orange/ NSW001P/2008/AU, denoted 'NSW001P') also exhibited an additional breakpoint near the ORF1-ORF2 junction (statistically significant in .4 RDP tests, after Bonferroni correction). Further analysis using similarity plots in Simplot v3.5.1 (Lole et al., 1999) The estimated breakpoints thus define three non-recombinant genomic regions of the 2008 variant: region 1 (1-5397 nt), region 2 (5398-5898 nt plus 6478-7509 nt) and region 3 (5899-6477 nt) (Fig. 2) . Separate phylogenies of these three regions were estimated using both ML (in PhyML) and Bayesian (in MrBayes) methods (Fig. 2) . The GTR+I+ 4 substitution model was used and 1000 bootstrap replicates were computed. The MrBayes analysis was performed using 10 7 steps, sampled every 2000. In the phylogeny of region 1 (mainly ORF1; Fig. 2 (Fig. 2 centre) , whereas in region 3 they clustered with the 2006b variants ( Fig. 2 right) .
Most groupings are supported by high bootstrap scores and Bayesian posterior probabilities (Fig. 2) . It is noteworthy that the 2008 variant group diverged from a node [indicated by clade support values 97/1 (53/.84) in the rightmost tree of Fig. 2 ] that is genetically distant (0.129 Phylogenetic-based analyses of recombination may be affected by convergent evolution leading to similar sets of amino acid substitutions in independent lineages. To examine such effects, we aligned the consensus sequences of different GII.4 variants, and removed the codon positions that are non-synonymous across variant lineages from the alignment. ML and Bayesian phylogenies were then estimated from these synonymous-site sequences (4710, 1250 and 412 bp in length for the regions 1, 2 and 3, respectively). The resultant tree topologies are largely congruent with regions 1, 2 and 3 phylogenies obtained from the full data (Fig. 2) . Clustering of 2008 and 2006b variants in the region 3 synonymous-site phylogeny has a lower ML bootstrap support (53 %), but quite high Bayesian posterior probability (0.84).
There are 35 viral isolates falling inside the 2008 variant lineage in ORF2 phylogeny (Fig. 1) . Only 11 of them have complete genomes that were confidently classified into two recombinant forms (Figs 2 and 3 Supplementary Fig. S2e ). Both mutation and recombination are important mechanisms in norovirus evolution (Bull & White, 2011; Rohayem et al., 2005) . As the entire clade of 2008 variant viruses appear to have a recombinant origin, intra-genotypic recombination may be more important in the emergence of new norovirus GII.4 variants than previously suggested (Lindesmith et al., 2008; Siebenga et al., 2007) . By exchanging the P2 domain, which contains numerous receptor-binding and antigenic sites (Donaldson et al., 2010; Lindesmith et al., 2008; Prasad et al., 1999; Siebenga et al., 2007; Tan et al., 2003) between two GII.4 lineages, the virus may be able to move more rapidly across its fitness landscape (Burke, 1997) in the face of high levels of immunity in the host population. Incorporation by recombination of a P2 domain from a minority strain that exhibits epitopes unfamiliar to host immunity may result in a fitter recombinant progeny. This scenario may explain the emergence of the 2008 variant, whose 2006b-like parent may represent a minority circulating lineage that has not been discovered in the past. The putative antigenic change caused by recombination within the P2 domain of norovirus may resemble the antigenic shift caused by reassortment in human influenza virus, whereby gene segments encoding viral surface proteins are replaced by those of other (usually zoonotic) origins and representing novel antigenicity to human. However, such an analogy must remain speculative until a robust way of classifying noroviruses by antigenicity becomes available.
Although the pathogenicity and transmissibility of the 2008 variant remain to be studied experimentally, its novel intra-genotypic recombinant nature and widespread global distribution suggest it should be a surveillance target. Although the prevalence of the 2008 variant among GII.4 infections varies geographically [~1 % in Canada (Pang et al., 2010) ,~8 % in France (Belliot et al., 2010) ,~22 % in Korea (Han et al., 2011) , and up to 80 % in South Africa (Mans et al., 2010) ], its increasing prevalence (Belliot et al., 2010; Motomura et al., 2010) and involvement in other recombinants raise a global public health concern. Despite this, we note that emergence of new GII.4 variants do not always cause dramatic outbreaks, e.g. during the 2009-2010 winter in the USA, when the 2008 variant first appeared there (Yen et al., 2011) . In general, recombination of the norovirus antigenic region could have major implications for the design and effectiveness of the norovirus vaccines.
